Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice

Nonalcoholic fatty liver disease (NAFLD), which is the most common liver disease, is associated with type 2 diabetes mellitus and metabolic syndrome. Although there is no consensus on the treatment of NAFLD, growing evidence suggests that tight glycemic control would contribute to the improvement of...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Panshuang, Jia, Yingli, Ma, Ang, He, Jinzhao, Shao, Chen, Li, Xiaowei, Wang, Shuyuan, Yang, Baoxue, Zhou, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437261/
https://www.ncbi.nlm.nih.gov/pubmed/36059948
http://dx.doi.org/10.3389/fphar.2022.934136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437261/
https://www.ncbi.nlm.nih.gov/pubmed/36059948
http://dx.doi.org/10.3389/fphar.2022.934136

Ejemplares similares